[go: up one dir, main page]

WO2008016666A3 - Entités chimiques, compositions et méthodes - Google Patents

Entités chimiques, compositions et méthodes Download PDF

Info

Publication number
WO2008016666A3
WO2008016666A3 PCT/US2007/017231 US2007017231W WO2008016666A3 WO 2008016666 A3 WO2008016666 A3 WO 2008016666A3 US 2007017231 W US2007017231 W US 2007017231W WO 2008016666 A3 WO2008016666 A3 WO 2008016666A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
chemical entities
compositions
certain chemical
muscle myosin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/017231
Other languages
English (en)
Other versions
WO2008016666A2 (fr
Inventor
Xiangping Qian
Jeffrey T Finer
Pu-Ping Lu
Chihyuan Grace Chuang
Bradley P Morgan
David J Morgans Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytokinetics Inc
Original Assignee
Cytokinetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytokinetics Inc filed Critical Cytokinetics Inc
Publication of WO2008016666A2 publication Critical patent/WO2008016666A2/fr
Publication of WO2008016666A3 publication Critical patent/WO2008016666A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des entités chimiques qui modulent la myosine des muscles lisses et/ou la myosine non musculaire, des compositions pharmaceutiques et des méthodes de traitement de pathologies et de troubles associés à la myosine des muscles lisses et/ou à la myosine non musculaire.
PCT/US2007/017231 2006-08-02 2007-08-01 Entités chimiques, compositions et méthodes Ceased WO2008016666A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83523706P 2006-08-02 2006-08-02
US60/835,237 2006-08-02

Publications (2)

Publication Number Publication Date
WO2008016666A2 WO2008016666A2 (fr) 2008-02-07
WO2008016666A3 true WO2008016666A3 (fr) 2008-07-24

Family

ID=38997710

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/017231 Ceased WO2008016666A2 (fr) 2006-08-02 2007-08-01 Entités chimiques, compositions et méthodes

Country Status (1)

Country Link
WO (1) WO2008016666A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ589825A (en) 2008-06-19 2012-11-30 Takeda Pharmaceutical Heterocyclic compound and use thereof
EP3193600A4 (fr) * 2014-09-10 2018-05-23 Epizyme, Inc. Inhibiteurs de smyd
WO2020097398A1 (fr) 2018-11-07 2020-05-14 Dana-Farber Cancer Institute, Inc. Dérivés benzothiazoles et dérivés 7-aza benzothiazoles comme inhibiteurs de la janus kinase 2 et leurs utilisations
CN115151540A (zh) 2019-12-02 2022-10-04 风暴治疗有限公司 作为mettl3抑制剂的多杂环化合物
US11691963B2 (en) 2020-05-06 2023-07-04 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
US12043632B2 (en) 2020-12-23 2024-07-23 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
EP4430042A1 (fr) 2021-11-09 2024-09-18 Ajax Therapeutics, Inc. 6-hetero-aryloxy-benzimidazoles et azabenzimidazoles en tant qu'inhibiteurs de jak2
TW202325289A (zh) 2021-11-09 2023-07-01 美商雅捷可斯治療公司 Ｊａｋ２抑制劑之形式及組合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070135435A1 (en) * 2005-11-02 2007-06-14 Xiangping Qian Certain chemical entities, compositions, and methods
US20070293530A1 (en) * 2006-06-14 2007-12-20 Methylgene Inc. Sulfamide and sulfamate derivatives as histone deacetylase inhibitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070135435A1 (en) * 2005-11-02 2007-06-14 Xiangping Qian Certain chemical entities, compositions, and methods
US20070293530A1 (en) * 2006-06-14 2007-12-20 Methylgene Inc. Sulfamide and sulfamate derivatives as histone deacetylase inhibitors

Also Published As

Publication number Publication date
WO2008016666A2 (fr) 2008-02-07

Similar Documents

Publication Publication Date Title
WO2008016643A3 (fr) Entités chimiques, compositions et méthodes
MX2010001692A (es) Ciertas entidades quimicas, composiciones y metodos.
MY172151A (en) Certain chemical entities, compositions and methods
TNSN08400A1 (en) Organic compounds and their uses
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
WO2010021693A3 (fr) Modulateurs de mif
EA201370208A1 (ru) Формы рифаксимина и их применение
IL233634A0 (en) Methods, compositions and kits for treating medical conditions
WO2008124660A3 (fr) Procédés et compositions pour le traitement du cancer
EA201200793A1 (ru) Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
BRPI0814941A2 (pt) Composição de tratamentode semente, e, método de tratamento de semente.
WO2009155001A3 (fr) Inhibiteurs de signalisation de la protéine wnt
WO2008016666A3 (fr) Entités chimiques, compositions et méthodes
WO2010062863A3 (fr) Compositions contenant des satiogènes et leurs procédés d'utilisation
IL201736A0 (en) Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
WO2006124748A3 (fr) Composes polycycliques et procedes pour les utiliser
WO2010034015A3 (fr) Modulation de la voie de complément alternative
IN2012DN02471A (fr)
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
WO2010011331A3 (fr) Compositions et procédés se rapportant à la fonction sirt1
WO2009002440A3 (fr) Compositions comprenant un arnsi de egfr humain et leurs procédés d'utilisation
WO2007121125A3 (fr) Composés organiques et leurs utilisations
WO2007061939A3 (fr) Dérivés de métabolites de l'inhibiteur de hdac fk228
EA200802072A1 (ru) Ликопин для лечения нарушения обмена веществ
WO2009009417A3 (fr) Compositions pharmaceutiques et procédés pour prévenir, traiter ou inhiber des maladies, des troubles ou des affections inflammatoires cutanés et des maladies, des troubles ou des affections associés à un appauvrissement en collagène

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07836435

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07836435

Country of ref document: EP

Kind code of ref document: A2